• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早孕期静脉导管质量保证中的累积和图和回顾性参数。

Cumulative sum plots and retrospective parameters in first-trimester ductus venosus quality assurance.

机构信息

Ultrasound Unit, Department of Obstetrics and Gynecology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.

出版信息

Prenat Diagn. 2013 Apr;33(4):384-90. doi: 10.1002/pd.4079. Epub 2013 Mar 14.

DOI:10.1002/pd.4079
PMID:23494871
Abstract

OBJECTIVE

This study aimed to evaluate the application of two quality assurance methods to the ductus venosus pulsatility index (DVPI), as a first-trimester aneuploidy marker, including retrospective assessment of distribution parameters and cumulative sum (CUSUM) plots.

METHODS

The DVPI was measured in 14 444 singleton fetuses at 11+0 to 13+6 weeks in two Fetal Medicine centers during a 4-year period. Sonologist-specific quality assurance distribution parameters, previously described for nuchal translucency, were assessed: the median multiples of the median (MoM), the logarithmic standard deviation of DVPI MoMs and the weekly DVPI percent decrease. Quality assurance results were compared between median MoMs and MoM-based CUSUM plots.

RESULTS

When sonologist-specific DVPI distribution parameters were retrospectively applied for quality assurance, a 1.0 median MoM, a 0.1 median logarithmic standard deviation and a 3.4 median weekly DVPI drop percentage were observed. CUSUM plots showed good agreement with 0.9-1.1 MoMs range for median MoM, in the assessment of sonologist-specific performances.

CONCLUSION

Retrospective and prospective DVPI quality assurance methods appear to be applicable to DVPI at 11+0 to 13+6 weeks. Its use should be encouraged if DVPI is to be added to first-trimester Down syndrome or cardiac defects screening.

摘要

目的

本研究旨在评估两种质量保证方法在静脉导管搏动指数(DVPI)中的应用,作为一项 11+0 至 13+6 周的唐氏综合征或心脏缺陷筛查的早期妊娠非整倍体标志物,包括对分布参数和累积和(CUSUM)图的回顾性评估。

方法

在两个胎儿医学中心,在 4 年期间,对 14444 例 11+0 至 13+6 周的单胎胎儿进行了静脉导管搏动指数的测量。评估了先前描述的用于颈项透明层的特定超声医生的质量保证分布参数:中位数倍数(MoM)的中位数、静脉导管搏动指数 MoM 的对数标准差和每周静脉导管搏动指数下降百分比。将质量保证结果与中值 MoM 与基于 MoM 的 CUSUM 图进行比较。

结果

当回顾性应用特定于超声医生的静脉导管搏动指数分布参数进行质量保证时,观察到 1.0 的中值 MoM、0.1 的中值对数标准差和 3.4 的中值每周静脉导管搏动指数下降百分比。CUSUM 图在评估特定于超声医生的性能时,与 0.9-1.1 MoM 的中值 MoM 范围具有良好的一致性。

结论

回顾性和前瞻性的静脉导管搏动指数质量保证方法似乎适用于 11+0 至 13+6 周的静脉导管搏动指数。如果要将静脉导管搏动指数添加到 11+0 至 13+6 周的唐氏综合征或心脏缺陷筛查中,应鼓励使用。

相似文献

1
Cumulative sum plots and retrospective parameters in first-trimester ductus venosus quality assurance.早孕期静脉导管质量保证中的累积和图和回顾性参数。
Prenat Diagn. 2013 Apr;33(4):384-90. doi: 10.1002/pd.4079. Epub 2013 Mar 14.
2
Updated reference ranges for the ductus venosus pulsatility index at 11-13 weeks.11-13 孕周静脉导管搏动指数的更新参考范围。
Fetal Diagn Ther. 2012;32(4):271-6. doi: 10.1159/000339413. Epub 2012 Aug 1.
3
Screening for trisomy 21 based on maternal age, nuchal translucency measurement, first trimester biochemistry and quantitative and qualitative assessment of the flow in the DV - the assessment of efficacy.基于孕妇年龄、颈部透明带测量、孕早期生化指标以及静脉导管血流的定量和定性评估进行21三体综合征筛查——效能评估
Ginekol Pol. 2017;88(9):481-485. doi: 10.5603/GP.a2017.0088.
4
Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?当颈项透明层厚度正常的胎儿进行染色体非整倍体和先天性心脏病筛查时,加入静脉导管是否有用?
Fetal Diagn Ther. 2012;32(1-2):138-43. doi: 10.1159/000335489. Epub 2012 May 15.
5
A preliminary retrospective study about the relationship between ductus venosus Doppler indices, nuchal translucency (NT) and biochemical markers in the first and second trimester screening tests.静脉导管多普勒指数、颈项透明层(NT)与早、中期唐氏筛查生化标志物的初步回顾性研究。
Gynecol Endocrinol. 2012 May;28(5):378-81. doi: 10.3109/09513590.2011.631633. Epub 2012 Feb 27.
6
Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening.产前胎儿唐氏综合征筛查中颈部透明带扫描的质量保证
J Matern Fetal Neonatal Med. 2012 Jul;25(7):1039-43. doi: 10.3109/14767058.2011.614658. Epub 2011 Oct 4.
7
First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers.
Prenat Diagn. 2005 Oct;25(10):901-5. doi: 10.1002/pd.1203.
8
Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.对有染色体或心脏异常高风险胎儿的静脉导管研究:与颈部透明带测量及胎儿结局的关系
Ultrasound Obstet Gynecol. 2001 Apr;17(4):288-94. doi: 10.1046/j.1469-0705.2001.00387.x.
9
Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy.
Prenat Diagn. 2003 Nov;23(11):921-6. doi: 10.1002/pd.716.
10
Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.静脉导管搏动指数作为唐氏综合征的产前筛查标志物:与联合检测和综合检测联合使用。
J Med Screen. 2009;16(3):112-8. doi: 10.1258/jms.2009.009043.

引用本文的文献

1
Doppler assessment of the ductus venosus and the tricuspid valve at 11-13 weeks: Reference ranges and development of sonographic quality assurance standards.孕11至13周时静脉导管和三尖瓣的多普勒评估:参考范围及超声质量保证标准的制定
Australas J Ultrasound Med. 2016 Feb 21;19(1):30-36. doi: 10.1002/ajum.12000. eCollection 2016 Feb.
2
Clinical Significance of Ductus Venosus Waveform as Generated by Pressure- volume Changes in the Fetal Heart.胎儿心脏压力-容积变化所产生的静脉导管波形的临床意义
Curr Cardiol Rev. 2019;15(3):167-176. doi: 10.2174/1573403X15666190115142303.